Benzinga's Top #PreMarket Gainers
April 21, 2014 at 08:08 AM EDT
Sarepta Therapeutics (NASDAQ: SRPT) soared 75.37% to $42.79 in the pre-market trading on announcement that it will file NDA for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.